NGF logo

Please use this identifier to cite or link to this item: http://ngfrepository.org.ng:8080/jspui/handle/123456789/2742
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFaisal Shuaib-
dc.date.accessioned2021-01-20T18:14:44Z-
dc.date.available2021-01-20T18:14:44Z-
dc.date.issued2021-01-20-
dc.identifier.citationFaisal, Shuaib (2021) Nigeria: Accelerated COVID-19 Vaccines Introduction and Deployment Planen_US
dc.identifier.urihttp://ngfrepository.org.ng:8080/jspui/handle/123456789/2742-
dc.description.abstractThe local production of vaccine is made up of many complex processes, and capital-intensive with several stages; each step requiring specific equipment, facility and skills relevant to each candidate vaccine. Given the Covid-19 pandemic, institutions, commercial developers, regulatory agencies, and researchers were working at an unprecedented speed to accelerate the development, review and recommendation of Covid-19 candidate vaccines within 10-12 months.en_US
dc.language.isoenen_US
dc.publisherNPHCDAen_US
dc.subjectNIGERIAen_US
dc.subjectCOVID-19en_US
dc.subjectVACCINESen_US
dc.subjectDEPLOYMENTen_US
dc.subjectPLANen_US
dc.titleNIGERIA: ACCELERATED COVID-19 VACCINES INTRODUCTION AND DEPLOYMENT PLANen_US
dc.typePresentationen_US
Appears in Collections:PRESENTATIONS - 1ST NGF MEETING JANUARY 2021

Files in This Item:
File Description SizeFormat 
Nigeria Covid19 Vaccine Deployment Plan.ppt5.98 MBMicrosoft PowerpointView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.